Clinical Trials on Gastroenteritis Escherichia Coli in Belgium

Total 385 results

Janssen Research & Development, LLC

Active, not recruiting

A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

Extraintestinal Pathogenic Escherichia Coli Prevention

United States, France, Belgium, Spain, Netherlands
Janssen Research & Development, LLC

Active, not recruiting

A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older (Engage)

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

United States, Poland, Belgium, Canada
Pherecydes Pharma

Unknown

Evaluation of Phage Therapy for the Treatment of Escherichia Coli and Pseudomonas Aeruginosa Wound Infections in Burned Patients (PHAGOBURN)

Wound Infection

Belgium, France, Switzerland
Astel Medica

Completed

First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic (BACTECOLIC)

Colic

Belgium
University Hospital, Ghent

Enrolling by invitation

Validation of the Global Polypectomy Assessment Tool (GPAT) (GPAT)

Colo-rectal Cancer | Colorectal Adenoma | Colorectal Polyp

Belgium
Université Catholique de Louvain

Recruiting

Clinical Use of Cold and Contact Heat-evoked Potentials: Normative Values

Establishing Normative Values of Cold and Contact Heat-evoked Potentials

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Recruiting

An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE)

Crohn Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Active, not recruiting

Loss of RESponse to Ustekinumab Treated by Dose Escalation (REScUE)

Crohn Disease

Belgium
Abivax S.A.

Unknown

Safety Evaluation of ABX464 in Patients With Moderate to Severe Active Crohn's Disease

Crohn Disease

Belgium
Tillotts Pharma AG

Completed

EPANOVA in Crohn's Disease, Study 1 (EPIC-1)

Crohn's Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Schering-Plough; Centocor BV

Completed

Top Down Versus Step Up Strategies in Crohn's Disease

Crohn's Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

The Effects of a Mindfulness Based Intervention on IBD Disability (EMBODY)

Crohn Disease

Belgium
KU Leuven

Completed

Prebiotic Effect on Metabolites in Crohn's Disease

Crohn Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients (KOPOF)

Adenomatous Polyposis Coli | Colitis,Ulcerative | Reservoir, Ileoanal

Belgium
KU Leuven
Fund for Scientific Research, Flanders, Belgium

Completed

Mucosal Gene Expression Defects in IBD

Inflammatory Bowel Diseases

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

Crohn's Disease

Belgium
Niti Medical Technologies Ltd.

Completed

End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study

Colorectal Cancer | Diverticulitis

Belgium
University of Liege
Centre Hospitalier Universitaire de Liege

Recruiting

MSC Intratissular Injection in Crohn Disease Patients (MSC)

Efficacy and Safety

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Recruiting

Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases (MODIFI)

Inflammatory Bowel Diseases

Belgium
Erasme University Hospital

Terminated

Endomina Diverticulum

Oesophageal Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

COmbinAtion Therapy of dieT With biologicalS for Crohn's Disease: the OATS Study (OATS)

Inflammatory Bowel Diseases | Crohn Disease | Diet, Healthy

Belgium
University of Liege

Completed

Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease (ACHILLE)

Inflammatory Bowel Diseases | Exercise Therapy

Belgium
GlaxoSmithKline

Completed

PBMC (Peripheral Blood Mononuclear Cells) /Lymphocyte SPECT (Single Photon Emission Computerized Tomography) Imaging in Crohn's Disease

Crohn's Disease

Netherlands, Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Completed

Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)

CD

Belgium, France
KU Leuven

Completed

Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Inflammatory Bowel Diseases

Belgium
Pieter Dewint, MD PhD

Completed

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders (SafE-OrBi)

Inflammatory Bowel Diseases

Belgium
University of Liege

Terminated

Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders

Crohn's Disease

Belgium
McNeil AB

Completed

Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold

Headache | Nasal Congestion | Common Cold

Belgium
Centre Hospitalier Universitaire de Liege

Recruiting

Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?

Efficacy | Safety Issues

Belgium
Universitaire Ziekenhuizen KU Leuven
Janssen, LP

Recruiting

Stelara fOr ChRonic AntibioTic rEfractory pouchitiS (SOCRATES)

Pouchitis

Belgium
Universitaire Ziekenhuizen KU Leuven
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Unknown

Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny (HELP-AID)

Crohn Disease | Colitis, Ulcerative

Belgium
Shire

Completed

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Colitis, Ulcerative

Belgium
Fast Forward Pharmaceuticals

Unknown

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Crohn's Disease

Belgium, Netherlands
Abivax S.A.
Orion Corporation, Orion Pharma

Active, not recruiting

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Imelda GI Clinical Research Center

Completed

pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis (APOLLO)

Ulcerative Colitis

Belgium
KU Leuven

Completed

Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Importance of Peritoneal Free Fluid Cultures in Acute Appendicitis (IFFSA)

Appendicitis

Belgium
Abivax S.A.

Completed

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
University of Liege; University Hospital, Ghent; Imelda Hospital, Bonheiden; AZ... and other collaborators

Completed

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis (CEDAR UC)

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis

Non-allergic Rhinitis

Belgium
Shire

Completed

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium
Hasselt University
Radboud University Medical Center; Jessa Hospital

Unknown

The Hasselt APPendicitis Immunology and Environmental Cohort STudy (HAPPIEST)

Appendicitis

Belgium, Netherlands
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Erasme University Hospital

Completed

MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) (MAGUS)

Diverticulum, Esophageal | Post Gastric Surgery Syndrome

Belgium
Universitaire Ziekenhuizen KU Leuven
Imelda GI Clinical Research Center; Sapporo Medical University

Unknown

PRognOstiC valuE of rEd Density in Ulcerative Colitis (PROCEED-UC)

Ulcerative Colitis

Belgium
Exeliom Biosciences
Alimentiv Inc.

Recruiting

EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease (MAINTAIN)

Crohn Disease

Poland, Belgium
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Unknown

Golimumab Dried Blood Spot Analysis (GOUDA)

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Randomized Trial Comparing Laparoscopic-assisted Rectosigmoid Resection Versus Laparoscopic Rectosigmoid Resection With Transrectal Specimen Retrieval (LATA)

Symptomatic Recurrent Diverticular Disease | Benign Adenomatous Sigmoidal Polyp, Requiring Surgery | Early Non-transmural Sigmoidtumor

Belgium
Arena Pharmaceuticals

Terminated

Efficacy and Safety of Etrasimod (APD334) in Inflammatory Bowel Disease Patients With Active Skin Extra-intestinal Manifestations

Inflammatory Bowel Diseases | Skin Extra-intestinal Manifestations

Belgium, Germany, Serbia

Clinical Trials on Gastroenteritis Escherichia Coli in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations